DIALYSIS · CCN 742598

USRC Sharpstown

Houston, TX 77074

DialysisProfitUS Renal Care, Inc.
$4.1M
TOTAL REVENUE
1.1%
OPERATING MARGIN
1 / 5
STAR RATING
11
QUALITY MEASURES
US Renal Care, Inc.
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$4.1M
Total costs
$4.0M
Operating income (rev − costs)
$43K
Operating margin
1.1%
Total charges
$4.1M
Total treatments
10,502
Dialysis stations
24

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

11 quality measures

MeasureScoreDenominatorPeriod
Percent of Adult HD Patients with Kt/V >= 1.2
DFC_ADULT_HD_KTV
9284—
Fistula Rate
DFC_FISTULA_RATE
49.688—
Five Star Rating
DFC_FIVE_STAR
1——
First Year Standardized Kidney Transplant Waitlist Ratio
DFC_FYSWR
047—
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
0——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
209.819—
Percentage of Adult Patients with Hypercalcemia
DFC_HYPERCALCEMIA
184—
Standard Infection Ratio (SIR)
DFC_INFECTION_RATIO
0.11——
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
3788—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
1.586—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
29.724—